Fortis Healthcare [FORTIS] vs Krishna Institute of [KIMS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Fortis Healthcare Ltd. wins in 13 metrics, Krishna Institute of Medical Sciences Ltd. wins in 6 metrics, with 0 ties. Fortis Healthcare Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fortis Healthcare Ltd. | Krishna Institute of Medical Sciences Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 72.46 | 91.01 | Fortis Healthcare Ltd. |
| Price-to-Book Ratio | 7.40 | 12.01 | Fortis Healthcare Ltd. |
| Debt-to-Equity Ratio | 32.96 | 123.72 | Fortis Healthcare Ltd. |
| PEG Ratio | -3.35 | -2.27 | Krishna Institute of Medical Sciences Ltd. |
| EV/EBITDA | 38.35 | 43.39 | Fortis Healthcare Ltd. |
| Profit Margin (TTM) | 10.94% | 8.29% | Fortis Healthcare Ltd. |
| Operating Margin (TTM) | 17.02% | 12.05% | Fortis Healthcare Ltd. |
| EBITDA Margin (TTM) | 17.02% | 12.05% | Fortis Healthcare Ltd. |
| Return on Equity | 8.44% | 15.90% | Krishna Institute of Medical Sciences Ltd. |
| Return on Assets (TTM) | 5.65% | 6.70% | Krishna Institute of Medical Sciences Ltd. |
| Free Cash Flow (TTM) | $5.77B | $-4.27B | Fortis Healthcare Ltd. |
| Dividend Yield | 0.12% | N/A | N/A |
| 1-Year Return | 31.35% | 15.46% | Fortis Healthcare Ltd. |
| Price-to-Sales Ratio (TTM) | 7.94 | 7.52 | Krishna Institute of Medical Sciences Ltd. |
| Enterprise Value | $722.34B | $306.34B | Fortis Healthcare Ltd. |
| EV/Revenue Ratio | 8.23 | 8.45 | Fortis Healthcare Ltd. |
| Gross Profit Margin (TTM) | 55.42% | 80.26% | Krishna Institute of Medical Sciences Ltd. |
| Revenue per Share (TTM) | $116 | $91 | Fortis Healthcare Ltd. |
| Earnings per Share (Diluted) | $12.74 | $7.49 | Fortis Healthcare Ltd. |
| Beta (Stock Volatility) | 0.67 | 0.11 | Krishna Institute of Medical Sciences Ltd. |
Fortis Healthcare Ltd. vs Krishna Institute of Medical Sciences Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fortis Healthcare Ltd. | -1.03% | -0.90% | 1.71% | 21.32% | 12.69% | 8.84% |
| Krishna Institute of Medical Sciences Ltd. | -1.94% | -3.91% | 1.08% | 19.15% | 14.89% | 24.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fortis Healthcare Ltd. | 31.35% | 219.26% | 326.88% | 512.08% | 521.49% | 885.42% |
| Krishna Institute of Medical Sciences Ltd. | 15.46% | 140.42% | 285.51% | 285.51% | 285.51% | 285.51% |
Performance & Financial Health Analysis: Fortis Healthcare Ltd. vs Krishna Institute of Medical Sciences Ltd.
| Metric | FORTIS | KIMS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹699.66B | ₹262.07B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,586,827 | 498,054 |
| 90 Day Avg. Volume | 1,692,133 | 371,629 |
| Last Close | ₹980.15 | ₹769.85 |
| 52 Week Range | ₹743.65 - ₹1,104.30 | ₹575.80 - ₹811.00 |
| % from 52W High | -11.24% | -5.07% |
| All-Time High | ₹1,104.30 (Oct 17, 2025) | ₹811.00 (Jun 08, 2026) |
| % from All-Time High | -11.24% | -5.07% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.29% |
| Quarterly Earnings Growth | -0.22% | -0.40% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.08% |
| Operating Margin (TTM) | 0.17% | 0.12% |
| Return on Equity (TTM) | 0.08% | 0.16% |
| Debt to Equity (MRQ) | 32.96 | 123.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹124.78 | ₹56.74 |
| Cash per Share (MRQ) | ₹5.62 | ₹3.00 |
| Operating Cash Flow (TTM) | ₹10.16B | ₹4.98B |
| Levered Free Cash Flow (TTM) | ₹7.74B | ₹3.85B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.12% | N/A |
| Last 12-Month Dividend | ₹1.00 | N/A |
Valuation & Enterprise Metrics Analysis: Fortis Healthcare Ltd. vs Krishna Institute of Medical Sciences Ltd.
| Metric | FORTIS (Apr 24, 2026) | KIMS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 72.46 | 91.01 |
| Forward P/E | 48.33 | 53.92 |
| PEG Ratio | -3.35 | -2.27 |
| Price to Sales (TTM) | 7.94 | 7.52 |
| Price to Book (MRQ) | 7.40 | 12.01 |
| Market Capitalization | ||
| Market Capitalization | ₹699.66B | ₹262.07B |
| Enterprise Value | ₹722.34B | ₹306.34B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.23 | 8.45 |
| Enterprise to EBITDA | 38.35 | 43.39 |
| Risk & Other Metrics | ||
| Beta | 0.67 | 0.11 |
| Book Value per Share (MRQ) | ₹124.78 | ₹56.74 |
Financial Statements Comparison: Fortis Healthcare Ltd. vs Krishna Institute of Medical Sciences Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | FORTIS (2025) | KIMS (2025) |
|---|---|---|
| Revenue/Sales | 77.24B | 30.04B |
| Cost of Goods Sold | 35.39B | 11.26B |
| COGS % of Revenue | 45.8% | 37.5% |
| Gross Profit | 41.85B | 18.77B |
| Gross Margin | 54.2% | 62.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 11.93B | 6.16B |
| Operating Margin | 15.4% | 20.5% |
| EBITDA | 16.43B | 7.97B |
| EBITDA Margin | 21.3% | 26.5% |
| Pre-Tax Income | 10.07B | 5.58B |
| Pre-Tax Income % of Revenue | 13.0% | 18.6% |
| Income Tax | 1.98B | 1.43B |
| Income Tax % of Revenue | 2.6% | 4.8% |
| Net Income (Profit) | 8.09B | 4.15B |
| Profit Margin | 10.5% | 13.8% |
Balance Sheet & Liquidity Metrics
| Metric | FORTIS (2025) | KIMS (2025) |
|---|---|---|
| Cash & Equivalents | 1.40B | 560.00M |
| Total Current Assets | 14.71B | 6.97B |
| Total Current Assets % of Revenue | 19.0% | 23.2% |
| Total Current Liabilities | 16.07B | 8.36B |
| Total Current Liabilities % of Revenue | 20.8% | 27.8% |
| Long-Term Debt | 23.11B | 22.87B |
| Long-Term Debt % of Revenue | 29.9% | 76.2% |
| Total Shareholders Equity | 91.69B | 24.19B |
| Retained Earnings | 6.54B | 10.35B |
| Retained Earnings % of Revenue | 8.5% | 34.5% |
| Property, Plant & Equipment | 22.30B | 11.47B |
Cash Flow Statement Comparison
| Metric | FORTIS (2025) | KIMS (2025) |
|---|---|---|
| Operating Cash Flow | 10.16B | 4.98B |
| Operating Cash Flow % of Revenue | 13.2% | 16.6% |
| Capital Expenditures | -8.32B | -9.62B |
| Free Cash Flow | 5.77B | -4.27B |
| FCF Margin | 7.5% | -14.2% |
| Debt Repayment | -1.98B | -837.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FORTIS | KIMS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 754.96M | 400.14M |
| Float Shares | 489.31M | 232.50M |
| % Held by Insiders | 35.19% | 43.35% |
| % Held by Institutions | 46.99% | 40.36% |
| % Held by Public | 17.82% | 16.29% |
Dividend Analysis & Yield Comparison: Fortis Healthcare Ltd. vs Krishna Institute of Medical Sciences Ltd.
| Metric | FORTIS | KIMS |
|---|---|---|
| Last 12-Month Dividend | ₹1.00 | N/A |
| Last 12-Month Dividend Yield | 0.12% | N/A |
| 3-Year Avg Annual Dividend | ₹1.00 | N/A |
| 3-Year Avg Dividend Yield | 0.21% | N/A |
| 3-Year Total Dividends | ₹3.00 | N/A |
| Ex-Dividend Date | Jul 25, 2025 | N/A |